Dr.Reddy's Lab - Launch of Cinacalcet Tablets - Angel Broking

Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd

Dr. Reddy's Laboratories Ltd. along with its subsidiaries together announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA). The Sensipar brand and generic market had U.S. sales of approximately $312 million MAT for the most recent twelve months ending in July 2020 according to IQVIA Health*. Dr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30. This is a positive development for Dr. Reddy's Laboratories Ltd.

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.5113.8 as compared to the previous close of Rs. 5187.05. The total number of shares traded during the day was 53711 in over 5197 trades.

The stock hit an intraday high of Rs. 5259.4 and intraday low of 5092.95. The net turnover during the day was Rs. 276679721.

Source : Equity Bulls

Keywords